GSGG — Destiny Alliance Biotechnology Cashflow Statement
0.000.00%
FinancialsMicro Cap
Annual cashflow statement for Destiny Alliance Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.023 | -0.015 | -0.011 | -0.016 | -0.024 |
Depreciation | |||||
Non-Cash Items | — | — | — | — | 0.007 |
Unusual Items | |||||
Changes in Working Capital | 0.007 | -0.005 | 0.01 | 0.003 | 0.007 |
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.016 | -0.02 | -0.001 | -0.013 | -0.009 |
Financing Cash Flow Items | 0.016 | 0.02 | 0.001 | 0.013 | 0.009 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0.016 | 0.02 | 0.001 | 0.013 | 0.009 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0 | 0 | 0 | 0 | 0 |